IR@PKUHSC  > 北京大学基础医学院  > 病理学系
学科主题基础医学
Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer
Xi, Chenguang1; Ren, Caixia2; Hu, Ajin1; Lin, Jie3; Yao, Qian4; Wang, Yue1; Gao, Zifen1; An, Xiuli5,6; Liu, Congrong1,7
关键词Protein 4.1N Epithelial ovarian cancer Tumor progression
刊名GYNECOLOGIC ONCOLOGY
2013-12-01
DOI10.1016/j.ygyno.2013.08.015
131期:3页:764-771
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Obstetrics & Gynecology
研究领域[WOS]Oncology ; Obstetrics & Gynecology
关键词[WOS]PROSTATE-CANCER ; SUPPRESSOR DAL-1/4.1B ; MEMBRANE ; CELLS ; MOUSE ; GENE ; METHYLATION ; METASTASIS ; CARCINOMA ; FAMILY
英文摘要

Objective. Protein 4.1N (4.1N) is a member of the Protein 4.1 family that is involved in cellular processes such as cell adhesion, migration and signaling. In this study, we evaluated the expression of 4.1N protein and its potential roles in epithelial ovarian cancer (EOC) tumorigenesis and progression.

Methods. 4.1N protein expression was investigated in a total of 280 samples including 74 normal tissues, 35 benign, 30 borderline and 141 malignant epithelial ovarian tumors by immunohistochemistry. Correlation between 4.1N expression levels and clinicopathologic features was statistically analyzed. The expression of 4.1N in EOC cell lines was examined by western blotting.

Results. Immunohistochemistry analysis revealed that, although there was no loss of 4.1N expression in normal tissues and benign tumors, absence of Protein 4.1N was significantly more common in EOCs (44.0%) than in borderline tumors (3.3%) (p < 0.001). Furthermore, loss or decreased expression of 4.1N protein expression was correlated with malignant potential of the tumors (14.3% in benign tumors, 56.7% in borderline tumors and 92.9% in malignancy) (p < 0.001). In EOC samples, loss of 4.1N protein was significantly associated with advanced-stage (p = 0.004), ascites (p = 0.009), omental metastasis (p = 0.018), suboptimal debulking (p = 0.024), poorly histological differentiation (p = 0.009), high-grade serous carcinoma (p = 0.001), short progression-free-survival (p = 0.018) and poor chemosensitivity to first-line chemotherapy (p = 0.029). Moreover, western blotting analysis revealed that expression of 4.1N protein Was lost in 4/8 (50%) EOC cell lines.

Conclusions. 4.1N protein expression level was significantly decreased during malignant transformation of epithelial ovarian tumors and that loss of 4.1N expression was closely correlated to poorly differentiated and biologically aggressive EOCs. (C) 2013 Elsevier Inc. All rights reserved.

语种英语
WOS记录号WOS:000327923400048
项目编号7082055 ; 2009CB521805 ; (2008)890
资助机构Beijing Municipal Natural Science Foundation of China ; National Basic Research Program of China (973 Program) ; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
版本出版稿
条目标识符http://ir.bjmu.edu.cn/handle/400002259/64910
专题北京大学基础医学院_病理学系
北京大学基础医学院
作者单位1.Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China
2.Peking Univ, Hlth Sci Ctr, Dept Histol & Embryol, Beijing 100191, Peoples R China
3.China Japan Friendship Hosp, Dept Pathol, Beijing 100029, Peoples R China
4.Capital Med Univ, Beijing Tongren Hosp, Dept Pathol, Beijing 100005, Peoples R China
5.New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10055 USA
6.Zhengzhou Univ, Dept Bioengn, Zhengzhou 450051, Peoples R China
7.Peking Univ, Hosp 3, Dept Pathol, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Xi, Chenguang,Ren, Caixia,Hu, Ajin,et al. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer[J]. GYNECOLOGIC ONCOLOGY,2013,131(3):764-771.
APA Xi, Chenguang.,Ren, Caixia.,Hu, Ajin.,Lin, Jie.,Yao, Qian.,...&Liu, Congrong.(2013).Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.GYNECOLOGIC ONCOLOGY,131(3),764-771.
MLA Xi, Chenguang,et al."Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer".GYNECOLOGIC ONCOLOGY 131.3(2013):764-771.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Defective expression(1306KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xi, Chenguang]的文章
[Ren, Caixia]的文章
[Hu, Ajin]的文章
百度学术
百度学术中相似的文章
[Xi, Chenguang]的文章
[Ren, Caixia]的文章
[Hu, Ajin]的文章
必应学术
必应学术中相似的文章
[Xi, Chenguang]的文章
[Ren, Caixia]的文章
[Hu, Ajin]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。